Waagstein F - Search Results

1

Ventricular adenine nucleotide translocator mRNA is upregulated in dilated cardiomyopathy.

Sylvén C, Lin L, Jansson E, Sotonyi P, Fu LX, Waagstein F, Hjalmarsson A, Marcus C, Brönnegård M. Sylvén C, et al. Among authors: waagstein f. Cardiovasc Res. 1993 Jul;27(7):1295-9. doi: 10.1093/cvr/27.7.1295. Cardiovasc Res. 1993. PMID: 8252591

2

Increase in functional activity rather than in amount of Gi-alpha in failing human heart with dilated cardiomyopathy.

Fu LX, Liang QM, Waagstein F, Hoebeke J, Sylvén C, Jansson E, Sotonyi P, Hjalmarson A. Fu LX, et al. Among authors: waagstein f. Cardiovasc Res. 1992 Oct;26(10):950-5. doi: 10.1093/cvr/26.10.950. Cardiovasc Res. 1992. PMID: 1336712

3

Na,K-ATPase receptor subunits alpha 1, alpha 2 and alpha 3 mRNA in dilated cardiomyopathy.

Sylvén C, Jansson E, Sotonyi P, Waagstein F, Brönnegård M. Sylvén C, et al. Among authors: waagstein f. Biol Pharm Bull. 1995 Jun;18(6):907-9. doi: 10.1248/bpb.18.907. Biol Pharm Bull. 1995. PMID: 7550131

4

Beta 1 and beta 2 adrenoceptor ligand and mRNA expression in dilated cardiomyopathy.

Sylvén C, Mischa G, Jansson E, Sotonyi P, Fu LX, Waagstein F, Brönnegård M. Sylvén C, et al. Among authors: waagstein f. Biol Pharm Bull. 1995 Oct;18(10):1430-4. doi: 10.1248/bpb.18.1430. Biol Pharm Bull. 1995. PMID: 8593450

5

Cardiac nuclear hormone receptor mRNA in heart failure in man.

Sylvén C, Jansson E, Sotonyi P, Waagstein F, Barkhem T, Brönnegård M. Sylvén C, et al. Among authors: waagstein f. Life Sci. 1996;59(22):1917-22. doi: 10.1016/s0024-3205(96)00539-5. Life Sci. 1996. PMID: 8950289

6

Oxygen free radical injury and Gs mediated signal transduction in the stunned porcine myocardium.

Fu LX, Ilebekk A, Kirkeben KA, Aksnes G, Waagstein F, Bergh CH, Hoebeke J, Liang QM, Hjalmarson A. Fu LX, et al. Among authors: waagstein f. Cardiovasc Res. 1992 May;26(5):449-55. doi: 10.1093/cvr/26.5.449. Cardiovasc Res. 1992. PMID: 1332826

7

Activity of receptors coupled to guanine nucleotide binding regulatory protein in doxorubicin induced cardiomyopathy.

Fu LX, Sjögren KG, Liang QM, Waagstein F, Hoebeke J, Hjalmarson A. Fu LX, et al. Among authors: waagstein f. Cardiovasc Res. 1991 Feb;25(2):145-50. doi: 10.1093/cvr/25.2.145. Cardiovasc Res. 1991. PMID: 1660348

8

Quality of life on treatment with metoprolol in dilated cardiomyopathy: results from the MDC trial. Metoprolol in Dilated Cardiomyopathy trial.

Wiklund I, Waagstein F, Swedberg K, Hjalmarsson A. Wiklund I, et al. Among authors: waagstein f. Cardiovasc Drugs Ther. 1996 Jul;10(3):361-8. doi: 10.1007/BF02627961. Cardiovasc Drugs Ther. 1996. PMID: 8877080 Clinical Trial.

9

Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy.

Fu LX, Magnusson Y, Bergh CH, Liljeqvist JA, Waagstein F, Hjalmarson A, Hoebeke J. Fu LX, et al. Among authors: waagstein f. J Clin Invest. 1993 May;91(5):1964-8. doi: 10.1172/JCI116416. J Clin Invest. 1993. PMID: 7683693 Free PMC article.

10

G proteins and calcium channels in myocardium.

Fu LX, Waagstein F, Hjalmarson A. Fu LX, et al. Among authors: waagstein f. Life Sci. 1991;48(24):2291-5. doi: 10.1016/0024-3205(91)90264-c. Life Sci. 1991. PMID: 1646360 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page